This article contains content that is written like an advertisement .(October 2019) |
Mani Menon | |
---|---|
Born | Trichur, Kerala, India | 9 July 1948 in
Nationality | American |
Occupation(s) | Director of the Vattikuti Urology Institute, Detroit, MI |
Spouse | Dr. Shameem Menon |
Children | 2 |
Website | www.henryford.com/physician-directory/m/menon-mani |
Mani Menon, born 9 July 1948 in Trichur, India, is an American surgeon whose work has helped to lay the foundation for modern Robotic Cancer Surgery. He is the founding director and the Raj and Padma Vattikuti Distinguished Chair of the Vattikuti Urology Institute at the Henry Ford Hospital in Detroit, MI, where he established the first cancer-oriented robotics program in the world. Menon is widely regarded for his role in the development of robotic surgery techniques for the treatment of patients with prostate, kidney, and bladder cancers, [1] [2] [3] as well as for the development of robotic kidney transplantation.
Menon is the recipient of the Gold Cystoscope Award (American Urological Association, 2001), Hugh Hampton Young award (American Urological Association, 2011), the Keyes Medal (American Association of Genitourinary surgeons, 2016), the prestigious B.C. Roy award (Awarded by the President of India, for his achievements in the fields of urology and robotics). [4]
He started his medical journey in 1964 from JIPMER where he did his MBBS. Menon developed a novel technique to measure androgen receptors in the human prostate. [5] At the age of 34, Menon became the chairman of the Urology department at the University of Massachusetts Medical Center in Worcester, Massachusetts. [5] During early career, his major contributions were in the field of kidney stone disease where he helped develop the use of intra-operative ultrasonography as an aid to renal stone management [6] and also devised methods to quantify citrate and oxalate levels in urine using ion chromatography. [7] [8]
In 1997, Menon was recruited to become chairman of urology at Henry Ford Hospital in to revive the prostate cancer program. In 2001, Henry Ford Hospital's urology department would receive a $20 million donation from the Vattikuti foundation. [9] The donation helped establish the Vattikuti Urology Institute (VUI) and would allow Menon's team to explore minimally invasive means of treating prostate cancer.
Menon and the staff at the VUI developed robotic procedures in general (for example, for bladder and kidney cancer) and prostatectomy in particular. [10] The robotic prostatectomy developed by Menon is called the "Vattikuti Institute Prostatectomy". Specialised laparoscopic instruments are used for the procedure. [10] [11] During the operation, images from a 3-D camera are projected to a remote console. The surgeons operates in virtual reality, observing the images on a screen. This technology serves to make the surgery less invasive and more precise. Menon has performed nearly 4,000 robotic prostatectomies [12] and is considered a world authority on the use robotic surgery for prostate cancer. [10] Under the leadership of Dr. Menon, the VUI established the first ever robotic training program in the world; for prostatectomy in 2000, [13] for cystectomy in 2003 [14] and for nephrectomy in 2006 [15] and most recently, in 2013, for kidney transplantation (trial ongoing).
In his years as Director of VUI, Menon has trained and mentored fellow surgeon, Ashutosh Tewari. To this day, Menon and Tewari collaborate on clinical manuscripts, research abstracts, conference lectures, and other projects. Both surgeons have significantly influenced the field of robotic surgery as it applies to urology, refining patient outcomes as well as boosting the surgical robot industry. [16]
In November 2011, Dr. Mani Menon was the keynote presenter and surgeon at prominent hospitals in six of India's major cities as part of the Vattikuti Foundation "Road Show". The Road Show was designed as a way to educate the medical community and public in India about the benefits of robotic surgery. The undertaking began in Gurgaon, and when it was over, two weeks later, 28 robotic procedures would demonstrate procedures in Urology and gynecology to interested audiences. Lectures and media interviews helped the public gain an understanding. [17]
Year | Honor / Award |
---|---|
2016 | Keyes Medal (2016) Awarded for "outstanding contributions in the advancement of Urology". This award is recognized as the greatest individual citation in the specialty by the American Association of Genitourinary Surgeons |
2017 | Menon Gold Medal Inaugural award of the Endourological Society and Society of Urological Robotic Surgery |
2017-2036 | Featured in Many Voices, One Nation A permanent exhibit at the Smithsonian National Museum of American History. This exhibition shows how the many voices of the American people have contributed to and continue to shape the nation. |
Urology, also known as genitourinary surgery, is the branch of medicine that focuses on surgical and medical diseases of the urinary system and the reproductive organs. Organs under the domain of urology include the kidneys, adrenal glands, ureters, urinary bladder, urethra, and the male reproductive organs.
Cystectomy is a medical term for surgical removal of all or part of the urinary bladder. It may also be rarely used to refer to the removal of a cyst. The most common condition warranting removal of the urinary bladder is bladder cancer.
Prostatectomy is the surgical removal of all or part of the prostate gland. This operation is done for benign conditions that cause urinary retention, as well as for prostate cancer and for other cancers of the pelvis.
Alexander Gershman is a Russian American surgeon He is considered one of the first surgeons in the world to apply the method of laparoscopic surgery and robotic-assisted surgery to urological surgery and is considered one of the world’s leading experts on minimally invasive surgery. After many years teaching, researching and conducting clinical studies on laparoscopic surgery throughout the world, Gershman is in private practice in Beverly Hills, California. His client list includes numerous Hollywood celebrities and professional athletes.
The Vattikuti Urology Institute (VUI) at the Henry Ford Hospital in Detroit, Michigan, is a clinical and research center for urological care.
Dr. Mahendra Bhandari is an Indian surgeon who has made substantial contributions to the specialty of urology, medical training, hospital administration, robotic surgery and medical ethics. For his efforts, he was awarded the Padma Shri by the government of India in 2000. Bhandari is currently Senior Bio-scientist and Director of Robotic Surgery Research & Education at the Vattikuti Urology Institute (VUI) in Detroit, MI. He was the Symposium coordinator of the International Robotic Urology Symposium. He also has been the CEO of the Vattikuti Foundation since 2010.
Urologic diseases or conditions include urinary tract infections, kidney stones, bladder control problems, and prostate problems, among others. Some urologic conditions do not affect a person for that long and some are lifetime conditions. Kidney diseases are normally investigated and treated by nephrologists, while the specialty of urology deals with problems in the other organs. Gynecologists may deal with problems of incontinence in women.
Ashutosh K. Tewari is the chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City. He is a board certified American urologist, oncologist, and principal investigator. Before moving to the Icahn School of Medicine in 2013, he was the founding director of both the Center for Prostate Cancer at Weill Cornell Medical College and the LeFrak Center for Robotic Surgery at NewYork–Presbyterian Hospital. Dr. Tewari was the Ronald P. Lynch endowed Chair of Urologic Oncology and the hospital's Director of Robotic Prostatectomy, treating patients with prostate, urinary bladder and other urological cancers. He is the current President of the Society for Urologic Robotic Surgeons (SURS) and the Committee Chair of the Prostate Program. Dr. Tewari is a world leading urological surgeon, and has performed over 10,000 robotically assisted procedures using the da Vinci Surgical System. Academically, he is recognized as a world-renowned expert on urologic oncology with over 250 peer reviewed published papers to his credit; he is on such lists as America's Top Doctors, New York Magazine's Best Doctors, and Who's Who in the World. In 2012, he was given the American Urological Association Gold Cystoscope Award for "outstanding contributions to the field of urologic oncology, most notably the treatment of prostate cancer and the development of novel techniques to improve the outcomes of robotic prostatectomy."
Douglas S. Scherr is an American surgeon and specialist in Urologic Oncology. He is currently the Clinical Director of Urologic Oncology at Weill Cornell Medicine. He also holds an appointment at the Rockefeller University as a Visiting Associate Physician. Scherr was the first physician at Cornell to perform a robotic prostatectomy as well as a robotic cystectomy.
Dr. Michael A. Palese, is an American urologist specializing in robotic, laparoscopic and endoscopic surgery, with a special emphasis on robotic surgeries relating to kidney cancer and kidney stone disease.
Craig G. Rogers, is an American urologist and the Chair of Urology Vattikuti Urology Institute at the Henry Ford Hospital in Detroit, Michigan. Rogers is known for pioneering robotic kidney surgeries using da Vinci Surgical System including single incision robotic surgeries. He was part of a team which pioneered the use of an ultrasound probe in robotic kidney surgery. On February 9, 2009, he performed the first twittered live robotic surgery.
Mark S. Soloway is an American emeritus professor of urology, known for his work on prostate, bladder and kidney cancer. From 1991 to 2010 he was professor and chairman of the University of Miami Miller School of Medicine (MSM) Department of Urology, and later became chief of urologic oncology at Memorial Hospital in Hollywood, Florida.
Michael D. Stifelman Michael D. Stifelman, M.D., is Chair of Urology at Hackensack University Medical Center, Director of Robotic Surgery at Hackensack Meridian Health, and Professor and Inaugural Chair of Urology at Hackensack Meridian School of Medicine.
Prokar Dasgupta is an Indian-born British surgeon and academic who is professor of surgery at the surgical academy at King's Health Partners, London, UK. Since 2002, he has been consultant urologist to Guy's Hospital, and in 2009 became the first professor of robotic surgery and urology at King's, and subsequently the chairman of the King's College-Vattikuti Institute of Robotic Surgery.
Vipul R. Patel, FACS is the founder and Medical Director of the AdventHealth’s Global Robotics Institute, founder and Vice President of the Society of Robotic Surgery, and founder and Editor Emeritus of The Journal of Robotic Surgery. He is board certified by the American Urological Association and specializes in robotic surgery for prostate cancer. On April 29, 2024, Dr. Vipul Patel completed his 18,000th robotic-assisted prostatectomy. The large volume of prostatectomies he has performed has enabled him to amass a large amount of statistical evidence regarding the efficacy of robotic techniques which has been used in developing and refining techniques. Patel credits the use of robotic assisted surgery with helping surgeons achieve better surgical outcomes with the "trifecta" of cancer control, continence and sexual function. In the course of his career Patel has led and participated in studies that have resulted in developing improved outcomes for robotic surgery and urologic treatment.
Terence John MillinFRCSI FRCS LRCP was a British-born Irish urological surgeon, who in 1945, introduced a surgical treatment of benign large prostates using the retropubic prostatectomy, later known as the Millin's prostatectomy, where he approached the prostate from behind the pubic bone and through the prostatic capsule, removing the prostate through the retropubic space and hence avoided cutting into the bladder. It superseded the technique of transvesical prostatectomy used by Peter Freyer, where the prostate was removed through the bladder.
The Urology Foundation (TUF) is a charity that works across the UK and Ireland with the aim of improving the knowledge and skills of surgeons who operate on diseases of the male and female urinary-tract system and the male reproductive organs and funds research to improve outcomes of all urological conditions and urological cancers.
Benjamin James Challacombe is a British consultant urological surgeon at Guy's & St Thomas' Hospitals, and at King’s College London, who specialises in the treatment of kidney and prostatic disease using robotic surgery. In 2005, he was part of the team that published the results of a randomised controlled trial of human versus telerobotics in the field of urology and renal transplant, one of the first of its kind.
Dipen J. Parekh is Chief Operating Officer at the University of Miami Health System, Chairman of Urology and the Dr. Victor Politano Endowed Chair in Clinical Urology at the Miller School of Medicine at University of Miami in Miami. He also serves as the Director of Robotic surgery at the University of Miami Health System.
Anthony James Costello, FRACS, FRCSI, is an Australian urologist. He served as head of the department of urology at the Royal Melbourne Hospital, Australia. He established the first robotic prostate cancer surgery programme in Australia and published the first series of men who had laser surgery for benign prostate enlargements.